EMEA-002649-PIP01-19

Key facts

Active substance
  • Ezetimibe
  • Atorvastatin
Therapeutic area
Cardiovascular diseases
Decision number
P/0429/2019
PIP number
EMEA-002649-PIP01-19
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of hypercholesterolaemia
Route(s) of administration
Oral use
Contact for public enquiries
ELPEN Pharmaceutical Co. Inc

E-mail: info@elpen.gr
Tel. +30 2106039326

 

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating